67% of successful medical logos contain blue as the main or additional color — this is not a coincidence or laziness of designers. The color blue activates the parasympathetic nervous system: in a person looking at saturated blue, heart rate decreases and blood pressure drops. For a patient who enters the clinic anxious, this literally works as a sedative at the level of perception, even before talking to a doctor.
There is also a cultural layer. 87% of people spontaneously recall blue and white when asked to describe NHS — the British healthcare system. This is the result of decades of consistent use of one color code (NHS Blue, #005EB8, Pantone 300). Such recognition is not created by a six-month campaign, it is built up over years of discipline in applying the color.
White is no less important in this context: it appears in 94% medical logos — either as a background or as a significant compositional element. The problem is that pure white in interior design and packaging is perceived as sterility and coldness. Therefore, in premium and wellness segments, white is increasingly being replaced with ivory, milk or pearl shades — they add warmth without losing the association with cleanliness.
There is no universal 'medical' palette — a multi-specialty clinic, pediatrics, a pharmacy, and a wellness center address different psychological tasks and should sound different.
| Type of facility | Color task | Working base |
|---|---|---|
| Multi-specialty clinic | Trust, authority, breadth of expertise | Blue + white, with dark blue allowed as a base for premium positioning |
| Pediatrics | Reduce child and parent anxiety, eliminate 'hospitality' | Pastel tones — peach, lavender, mint, combined with white |
| Wellness center / premium medicine | Calm, exclusivity, care | Turquoise, muted green, warm beige instead of sterile white |
| Pharmacy (retail) | Quick street recognition, association with health | Green + white or green + blue — readable from sign from 20-30 meters |
| Women's health | Softness, empathy, intimacy of theme | Pink, lavender paired with neutral gray or white |
Green alone deserves attention as a choice for pharmacies and preventive medicine: it requires minimal adaptation of the human eye and objectively reduces stress levels during prolonged visual contact — an important property for signs that people pass by every day.
Designers of medical brands almost everywhere violate the classical rule of proportions, flooding the logo with blue at 90% and leaving no space for emphasis. The working formula is simpler: dominant color — 60-70% of the entire visual system, secondary — 20-30%, accent — 5-10%. Accent is needed not for beauty, but as a navigation element: booking button on the website, office number, urgent signal in the patient interface.
A separate trend of recent years — soft gradients from dark blue to turquoise. Such a transition is visually perceived as a metaphor for improving the patient's condition, movement from anxiety to recovery, and it is increasingly used in health monitoring app interfaces.
Here, top articles give almost nothing, and the difference is fundamental — the drug's manufacturer, pharmacy network, and B2B-supplier of medical equipment solve different tasks with color.
| Segment | Logic of choice | Reference codes |
|---|---|---|
| Pharmaceutical production (brand drugs) | Strict, status blue — a signal of scientific reliability and regulatory compliance | Pfizer French Blue #0070BF (PMS 2175C); Orion Pharma Blue RGB 0/84/158 |
| Pharmacy retail | A warmer, more friendly palette — a buyer makes a decision quickly, emotionally | Green range #2E7D32–#43A047 in combination with white or soft blue |
| B2B medical services | Neutral corporate blue without a 'medical' accent, to avoid confusion with a clinic | Intense blue level NHS Blue #005EB8, often without green at all |
The premium segment almost always moves away from pure, glaring shades toward muted, smoky versions of the same colors — deep dark blue instead of bright blue, muted sage instead of acid green. Accessible, mass healthcare, on the other hand, uses more vivid and contrasting versions of the same colors — this is faster to read and cheaper to produce for signage and packaging.
The practical side of color choice in healthcare is regulated more strictly than in any other industry, and this rarely appears in articles about 'color psychology'.
This is the very point that marketers regularly underestimate, while pharmaceutical companies overestimate in the direction of redesign without research. Changing the color of a tablet leads to a 50% higher rate of discontinuation of medication compared to maintaining the familiar appearance of the drug. When changing the color of antiepileptic drugs, the risk of treatment interruption increases by 53% — patients with diagnosed epilepsy demonstrate significantly higher chances of non-persistence when the tablet color is changed — a figure that for a chronic condition means a real health risk. Every fifth patient, upon changing the tablet color, decides that they were given the wrong medication and seeks clarification or simply stops taking it.
The conclusion for a pharma brand is simple: rebranding the company's visual identity and the color of the tablet or capsule itself are two different decisions that cannot be changed simultaneously and without warning the patient. The logo can be updated within a month, but the color code of the drug itself should only be altered with long-term communication support and explanation on the packaging.
Most failures are repeated from project to project, and almost all of them are related not to aesthetics but to a lack of understanding of the physiology of perception.
Color in healthcare is not about logo aesthetics, but about the physiological and behavioral effect on a person who is often in a state of stress or fear. A mistake in choosing a shade here costs more than in any other industry: not sales, but literally commitment to treatment.
67% of successful medical logos contain blue as the main or additional color — this is not a coincidence or laziness of designers. The color blue activates the parasympathetic nervous system: in a person looking at saturated blue, heart rate decreases and blood pressure drops. For a patient who enters the clinic anxious, this literally works as a sedative at the level of perception, even before talking to a doctor.
There is also a cultural layer. 87% of people spontaneously recall blue and white when asked to describe NHS — the British healthcare system. This is the result of decades of consistent use of one color code (NHS Blue, #005EB8, Pantone 300). Such recognition is not created by a six-month campaign, it is built up over years of discipline in applying the color.
White is no less important in this context: it appears in 94% medical logos — either as a background or as a significant compositional element. The problem is that pure white in interior design and packaging is perceived as sterility and coldness. Therefore, in premium and wellness segments, white is increasingly being replaced with ivory, milk or pearl shades — they add warmth without losing the association with cleanliness.
There is no universal 'medical' palette — a multi-specialty clinic, pediatrics, a pharmacy, and a wellness center address different psychological tasks and should sound different.
| Type of facility | Color task | Working base |
|---|---|---|
| Multi-specialty clinic | Trust, authority, breadth of expertise | Blue + white, with dark blue allowed as a base for premium positioning |
| Pediatrics | Reduce child and parent anxiety, eliminate 'hospitality' | Pastel tones — peach, lavender, mint, combined with white |
| Wellness center / premium medicine | Calm, exclusivity, care | Turquoise, muted green, warm beige instead of sterile white |
| Pharmacy (retail) | Quick street recognition, association with health | Green + white or green + blue — readable from sign from 20-30 meters |
| Women's health | Softness, empathy, intimacy of theme | Pink, lavender paired with neutral gray or white |
Green alone deserves attention as a choice for pharmacies and preventive medicine: it requires minimal adaptation of the human eye and objectively reduces stress levels during prolonged visual contact — an important property for signs that people pass by every day.
Designers of medical brands almost everywhere violate the classical rule of proportions, flooding the logo with blue at 90% and leaving no space for emphasis. The working formula is simpler: dominant color — 60-70% of the entire visual system, secondary — 20-30%, accent — 5-10%. Accent is needed not for beauty, but as a navigation element: booking button on the website, office number, urgent signal in the patient interface.
A separate trend of recent years — soft gradients from dark blue to turquoise. Such a transition is visually perceived as a metaphor for improving the patient's condition, movement from anxiety to recovery, and it is increasingly used in health monitoring app interfaces.
Here, top articles give almost nothing, and the difference is fundamental — the drug's manufacturer, pharmacy network, and B2B-supplier of medical equipment solve different tasks with color.
| Segment | Logic of choice | Reference codes |
|---|---|---|
| Pharmaceutical production (brand drugs) | Strict, status blue — a signal of scientific reliability and regulatory compliance | Pfizer French Blue #0070BF (PMS 2175C); Orion Pharma Blue RGB 0/84/158 |
| Pharmacy retail | A warmer, more friendly palette — a buyer makes a decision quickly, emotionally | Green range #2E7D32–#43A047 in combination with white or soft blue |
| B2B medical services | Neutral corporate blue without a 'medical' accent, to avoid confusion with a clinic | Intense blue level NHS Blue #005EB8, often without green at all |
The premium segment almost always moves away from pure, glaring shades toward muted, smoky versions of the same colors — deep dark blue instead of bright blue, muted sage instead of acid green. Accessible, mass healthcare, on the other hand, uses more vivid and contrasting versions of the same colors — this is faster to read and cheaper to produce for signage and packaging.
The practical side of color choice in healthcare is regulated more strictly than in any other industry, and this rarely appears in articles about 'color psychology'.
This is the very point that marketers regularly underestimate, while pharmaceutical companies overestimate in the direction of redesign without research. Changing the color of a tablet leads to a 50% higher rate of discontinuation of medication compared to maintaining the familiar appearance of the drug. When changing the color of antiepileptic drugs, the risk of treatment interruption increases by 53% — patients with diagnosed epilepsy demonstrate significantly higher chances of non-persistence when the tablet color is changed — a figure that for a chronic condition means a real health risk. Every fifth patient, upon changing the tablet color, decides that they were given the wrong medication and seeks clarification or simply stops taking it.
The conclusion for a pharma brand is simple: rebranding the company's visual identity and the color of the tablet or capsule itself are two different decisions that cannot be changed simultaneously and without warning the patient. The logo can be updated within a month, but the color code of the drug itself should only be altered with long-term communication support and explanation on the packaging.
Most failures are repeated from project to project, and almost all of them are related not to aesthetics but to a lack of understanding of the physiology of perception.
Color in healthcare is not about logo aesthetics, but about the physiological and behavioral effect on a person who is often in a state of stress or fear. A mistake in choosing a shade here costs more than in any other industry: not sales, but literally commitment to treatment.